Merck KGaA

By Laura Lovett June 11, 2019
Less than a year after the blockchain-enabled genome sequencing startup's launch, Nebula Genomics is announcing its first pharma partnership with Merck KGaA’s EMD Serono. This early partnership will come in the form of a pilot program.  As part of the deal, EMD Serono will be able to use Nebula’s network of anonymized genomic data. This new pilot is specifically zeroing in on lung cancer patients...
By Dave Muoio November 20, 2018
Merck KGaA, Darmstadt, and Silicon Valley-area big data company Palantir Technologies announced a joint venture that will focus on building an analytics and collaborative technology platform for cancer researchers. Called Syntropy, the Boston-based effort will rely on Palantir Foundry to power its data integration platform. Any research data shared across participating groups will be transparent...